Side by side
Adamax vs Noopept
Both are discussed for cognition & mood. What this site records about each, side by side. Every figure is on the compound's own page with the source it came from.
| Adamax | Noopept | |
|---|---|---|
| What it is | A Semax derivative sold with adamantane-related branding. The least documented compound on this site, and that is saying something. | A Russian prescription nootropic, registered there since 1996. Not a peptide despite the name, and unapproved everywhere else. |
| EvidenceHow much human evidence exists, not how well it works. | Preclinical | Approved for another indication |
| Regulatory statusReviewed 2026-08-18 | Not approved anywhere and not studied anywhere. Sold as a research chemical with no published characterisation. | A registered prescription medicine in Russia since 1996 for cognitive impairment following stroke or injury. Not approved in the United States or the European Union, and controlled in the United Kingdom under the Psychoactive Substances Act. |
| Routes | Nasal | Oral |
| Cheapest per mgVials only, read from vendors' own listings and dated on the price index. | $2.86/mg | $0.67/mg |
| Median per mg | $7.28/mg | $1.03/mg |
| Vendors with a price | 20 | 3 |
| Storage once mixed | Refrigerated at 2–8 °C. Nasal solutions are handled more than injectables and are correspondingly easier to contaminate. | Not applicable. This is taken orally. |
Compare two other compounds · The full price index
This page is educational. It describes what published research reports, not what you should do. Peptides discussed here are largely not approved for human use, and nothing on BioAlmanac is medical advice. Nothing here ranks these two against each other. A table can show that one has more human evidence behind it or costs less per milligram; neither of those is a recommendation, and the right comparison for any person is one their doctor makes with them.